Valuation dashboard for Twist Bioscience Corporation (TWST) with P/E N/A, P/B 26.41, EV/EBITDA -118.21 and dividend yield 0.00%. DCF, Graham Number, EPS growth, peer multiples and dividend discount models plus sector comparison against other Healthcare companies.
Twist Bioscience Corporation operates as a leading synthetic biology firm, specializing in the production and sale of products developed from synthesized DNA. The company utilizes a unique DNA synthesis platform that facilitates the creation of artificial DNA by "writing" it directly onto silicon chips.
Analysis Summary
Twist Bioscience Corporation reported revenue of $376.6M in the most recent fiscal year, growing at a 5-year CAGR of 33.1%.
Trailing-twelve-month margins: gross margin 52.0%, operating margin -31.9%, net margin -31.7%.
At the current price of $188.05, TWST has negative trailing earnings (P/E not meaningful) and an ROE of -29.89%. Market capitalisation stands at $11.7B, placing it among large-cap names.
Balance sheet quality for TWST: current ratio of 3.6. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| Price / Book | 26.41 |
| EV / EBITDA | -118.21 |
| Dividend Yield | 0.00% |
Valuation Models
| DCF Fair Value | $-56.41 |
| vs Current Price | -130.0% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| TWST | Twist Bioscience Corporation | $11.7B | 26.41 | -29.9% | |
| EWTX | Edgewise Therapeutics, Inc. | $4.3B | 9.95 | -32.1% | |
| CLOV | Clover Health Investments, Corp. | $2.3B | 6.10 | -5.4% | |
| GRDN | Guardian Pharmacy Services, Inc. | $2.7B | 40.36 | 10.93 | 23.9% |
| 0QZU.L | Vertex Pharmaceuticals Incorporated | $134.2B | |||
| VRTX | Vertex Pharmaceuticals Incorporated | $128.1B | 29.38 | 6.21 | 21.2% |
| 0R2M.L | Regeneron Pharmaceuticals, Inc. | $78.8B | 17.35 | 2.37 | 13.8% |
| REGN | Regeneron Pharmaceuticals, Inc. | $75.7B | 17.55 | 2.40 | 14.4% |
Price
| Price | $188.05 |
| Market Cap | $11.7B |
| Exchange | NASDAQ |
| Country | US |
Profitability
| Return on Equity | -29.89% |
| Return on Invested Capital | -24.57% |
| Return on Assets | -20.33% |
| Gross Margin | 51.97% |
| Operating Margin | -31.91% |
| Net Margin | -31.66% |
Related companies: BGM · CLOV · EWTX · GPCR · GRDN · MESO · PRCT
Explore sector: Healthcare · Biotechnology
More sections of TWST: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Investment Academy — learn to analyze stocks